CH BIOTECH SER (08037) Subsidiary Secures Loan Facility of Up to RMB 180 Million

Stock News

Sep 11

CH BIOTECH SER (08037) announced that on September 9, 2025, Pengbo (Hainan) Boron Neutron Medical Technology Co., Ltd. (Pengbo Hainan), a limited liability company incorporated in China and an indirect wholly-owned subsidiary of the Company as of the announcement date, entered into a loan agreement with Qionghai Branch of Hainan Rural Commercial Bank Co., Ltd. as the lender, acting as the borrower.

Under the agreement, the lender has agreed to provide Pengbo Hainan with a loan facility of up to RMB 180 million in principal amount. The loan will provide additional support for the construction of the Boron Neutron Capture Therapy center, with the goal of opening and commencing operations by the end of 2025 to provide boron neutron therapy services to cancer patients in need.

Leveraging the supportive policies of the Boao Lecheng pilot zone and using this center as a demonstration project, the Group is committed to developing a network of Boron Neutron Capture Therapy centers covering China in the future, developing franchise hospitals to generate additional revenue streams.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1120506638"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1120506638\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1120506638?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-11 12:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120506638","market":"sh","top_or_hot":-1,"title":"CH BIOTECH SER (08037) Subsidiary Secures Loan Facility of Up to RMB 180 Million","media":"Stock News","content":"<p>CH BIOTECH SER (08037) announced that on September 9, 2025, Pengbo (Hainan) Boron Neutron Medical Technology Co., Ltd. (Pengbo Hainan), a limited liability company incorporated in China and an indirect wholly-owned subsidiary of the Company as of the announcement date, entered into a loan agreement with Qionghai Branch of Hainan Rural Commercial Bank Co., Ltd. as the lender, acting as the borrower.</p>\n<p>Under the agreement, the lender has agreed to provide Pengbo Hainan with a loan facility of up to RMB 180 million in principal amount. The loan will provide additional support for the construction of the Boron Neutron Capture Therapy center, with the goal of opening and commencing operations by the end of 2025 to provide boron neutron therapy services to cancer patients in need.</p>\n<p>Leveraging the supportive policies of the Boao Lecheng pilot zone and using this center as a demonstration project, the Group is committed to developing a network of Boron Neutron Capture Therapy centers covering China in the future, developing franchise hospitals to generate additional revenue streams.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CH BIOTECH SER (08037) Subsidiary Secures Loan Facility of Up to RMB 180 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCH BIOTECH SER (08037) Subsidiary Secures Loan Facility of Up to RMB 180 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-09-11 12:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CH BIOTECH SER (08037) announced that on September 9, 2025, Pengbo (Hainan) Boron Neutron Medical Technology Co., Ltd. (Pengbo Hainan), a limited liability company incorporated in China and an indirect wholly-owned subsidiary of the Company as of the announcement date, entered into a loan agreement with Qionghai Branch of Hainan Rural Commercial Bank Co., Ltd. as the lender, acting as the borrower.</p>\n<p>Under the agreement, the lender has agreed to provide Pengbo Hainan with a loan facility of up to RMB 180 million in principal amount. The loan will provide additional support for the construction of the Boron Neutron Capture Therapy center, with the goal of opening and commencing operations by the end of 2025 to provide boron neutron therapy services to cancer patients in need.</p>\n<p>Leveraging the supportive policies of the Boao Lecheng pilot zone and using this center as a demonstration project, the Group is committed to developing a network of Boron Neutron Capture Therapy centers covering China in the future, developing franchise hospitals to generate additional revenue streams.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"08037","symbol_name":"中国生物科技服务","start_time":0,"source_url":"","article_id":"1120506638","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120506638","pubTimestamp":1757565257,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"CH BIOTECH SER (08037) announced that on September 9, 2025, Pengbo (Hainan) Boron Neutron Medical Technology Co., Ltd. (Pengbo Hainan), a limited liability company incorporated in China and an...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"08037":"中国生物科技服务","BK1511":"疑似财技股","BK1219":"保健护理服务"},"translate_title":"CH BIOTECH SER(08037)附属公司取得最高人民币1.8亿元贷款融资","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"08037":1},"content_text":"CH BIOTECH SER (08037) announced that on September 9, 2025, Pengbo (Hainan) Boron Neutron Medical Technology Co., Ltd. (Pengbo Hainan), a limited liability company incorporated in China and an indirect wholly-owned subsidiary of the Company as of the announcement date, entered into a loan agreement with Qionghai Branch of Hainan Rural Commercial Bank Co., Ltd. as the lender, acting as the borrower.\nUnder the agreement, the lender has agreed to provide Pengbo Hainan with a loan facility of up to RMB 180 million in principal amount. The loan will provide additional support for the construction of the Boron Neutron Capture Therapy center, with the goal of opening and commencing operations by the end of 2025 to provide boron neutron therapy services to cancer patients in need.\nLeveraging the supportive policies of the Boao Lecheng pilot zone and using this center as a demonstration project, the Group is committed to developing a network of Boron Neutron Capture Therapy centers covering China in the future, developing franchise hospitals to generate additional revenue streams.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}